Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
[62]
RCT 3-armed trial |
200 people |
Proportion of people who had at least 1 general adverse effect
during the treatment phase
25% with keratinocyte lysate plus usual care 25% with vehicle plus usual care 22% with usual care alone Absolute numbers not reported |
Reported as not significant |
Not significant | |
[62]
RCT 3-armed trial |
200 people |
Proportion of people who had at least 1 general adverse effect
during follow-up period
16% with keratinocyte lysate plus usual care 17% with vehicle plus usual care 12% with usual care alone Absolute numbers not reported |
Reported as not significant |
Not significant |